SHA’s CEO, Dr. Michael C. Threatt, partners with Tracking-At-A-Glance® for case management software to meet the Resident Services Goal of the Roadmap 2030 We are humbled to receive our fifth FSS grant ...

Oracle's stock has whipsawed investors, finishing 2025 higher but suffering a brutal drawdown from its peak. The debate now ...

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced preliminary in ...